| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9fcb361fb41183db7db8101fe2754323 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-575 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56 |
| filingDate |
2020-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_11751318e4e1616c2f07e86e41b946a3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3796b6fc013be0ea0791bfceb2f4c432
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21a0980223c59892552d5e235da4b7d5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_adef7b480ce4aa1d21ccd2ef3a0c5265
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b874ac773631fdfc45189b42e024dc4c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac26f25a3014709dec90bc88c2e32192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed40bb9aebc5b02918995bf1c164819e |
| publicationDate |
2020-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-112043715-A |
| titleOfInvention |
Application of Ganoderma A in the preparation of medicines for improving the dysfunction of GABAergic neuron system |
| abstract |
The invention discloses the application of Ganoderma lucidum acid A in preparing a medicine for improving the abnormal function of GABAergic neuron system. Ganoderma A in the present invention can improve the abnormal function of GABAergic neuron system, and change the expression level of related mRNA in multiple GABAergic neurons and cholinergic neuron systems. It is confirmed by acute toxicity experiments of cells and animals that Ganoderma A is safe The dosage range is large, and it can be used in the preparation of drugs for improving the abnormal function of the GABAergic neuron system. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022142290-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113648316-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112618552-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113995761-A |
| priorityDate |
2020-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |